HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections.

Abstract
Implant-associated infections are often resistant to antibiotic therapy. Routine sensitivity tests fail to predict therapeutic success. Therefore experimental in vitro tests were sought that would better correlate with drug efficacy in device-related infections. The activity of six different antibiotics against methicillin-resistant Staphylococcus epidermidis was investigated. In vivo studies were performed with the guinea pig tissue-cage animal model; in vitro studies with minimum inhibiting and bactericidal concentrations, time-kill studies of growing and stationary-phase microorganisms, the killing of glass-adherent S. epidermidis. Drug efficacy on stationary and adherent microorganisms, but not minimum inhibiting concentrations, predicted the outcome of device-related infections. Rifampin cured 12 of 12 infections and was also the most efficient drug in any experimental in vitro test. Similarly, the failure of ciprofloxacin to eradicate foreign body infections correlated with its low efficacy on stationary-phase and adherent S. epidermidis.
AuthorsA F Widmer, R Frei, Z Rajacic, W Zimmerli
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 162 Issue 1 Pg. 96-102 (Jul 1990) ISSN: 0022-1899 [Print] United States
PMID2355207 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Animals
  • Anti-Bacterial Agents (pharmacokinetics, therapeutic use)
  • Bacterial Infections (drug therapy, etiology)
  • Bioprosthesis (adverse effects)
  • Diffusion Chambers, Culture
  • Disease Models, Animal
  • Guinea Pigs
  • Microbial Sensitivity Tests
  • Prostheses and Implants (adverse effects)
  • Staphylococcal Infections (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: